Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by davgroon Feb 27, 2023 1:13pm
99 Views
Post# 35307513

RE:RE:ATE Back to C$ 0.50 - High Volume Dump of Shares

RE:RE:ATE Back to C$ 0.50 - High Volume Dump of SharesDumpster, aren't you tired of being wrong on every stock you post about ?  I told you what was going to happen with ATE and here we are into the C$ 0.40s. 

Traders like myself are making buckets of money swing trading HEXO while you bash it on a daily basis.  VIBE is at its 52-week low while you continue to promote it.  NDVA is at its 52-week low while you keeping buy the falling knife.  You bash ATH everyday and it is moving higher even though oil is down.

You understand nothing about stocks or the market and it shows on a daily basis.  Stockhouse members ridicule almost every post you make.  You really should just put your money in GICs as you suck at the trading game.

That said, you are still my favourite TROLL and I will never put you on ignore because you keep me entertained.  Luv you Dumpster.

Duster340 wrote:
davgro wrote: Yo Dumpster,  I told you we would be back in the C$ 0.40s soon.  You really know nothing about trading or the markets.  Friday's jump to C$ 0.60 was just one buyer putting a market order in and taking out all orders at the ask.  Now someone has dumped a lot of shares in a market sell at the bid driving the stock price to a low not seen since December.  In fact this is the largest daily volume since mid December and there is stil a 1/2 a day of trading left.  I am still on the sidelines as this will continue to drift lower as no news will probably happen until April.
Nobody new there was going to be a big seller of the stock today, otherwise the stock would still be in the mid 50's. so if you think the stock would have gone back to the 40's without the huge sell you really know nothing and you have shown your stupidity today in your post. the bigger question is who is selling , is it an insider? could it be D.r. J Wallace selling off more shares.



<< Previous
Bullboard Posts
Next >>